Pennsylvania HB 1741: An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory syndrome-related illnesses.

Status: Re-committed to APPROPRIATIONS (as of 2022-06-14)

State: Pennsylvania · Session: 2021-2022 · Bill: HB 1741

Sponsors: Keefer, Bernstine, Borowicz, Cox, Diamond, Gillen, Greiner, Hamm, Hershey, Jones, Kauffman, Maloney, Rapp, Rowe, Ryan, Staats, Twardzik, Zimmerman

View Pennsylvania HB 1741 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.